New data show growing adoption of guidance to skip sentinel lymph node biopsy in older women with early breast cancer, though ...

Phase II Study of Eribulin Mesylate, a Halichondrin B Analog, in Patients With Metastatic Breast Cancer Previously Treated With an Anthracycline and a Taxane Of 97,314 patients, 20.8% underwent SLNB ...

Lymphatic mapping, a recent technique first developed for the management of melanoma, is based on the concept that information about the status of the entire lymphatic drainage from a tumor site could ...

MITO (Multicentre Italian Trials in Ovarian cancer): CERV 2 trial—A randomized phase II study of carboplatin and paclitaxel +/- cetuximab, in advanced and/or recurrent cervical cancer. This is an ASCO ...

Biopsy of the sentinel lymph node, the first lymph node to which fluid from a primary breast tumor drains, was associated with better arm function and better quality of life compared with standard ...

Please provide your email address to receive an email when new articles are posted on . Sentinel lymph node biopsy (SLNB) is a low-risk procedure that can reduce the need for complete lymph node ...

Limited data are available on survival outcomes after sentinel-lymph-node biopsy alone as compared with lymphadenectomy in cervical cancer. In this multicenter, randomized, noninferiority trial, we ...

Please provide your email address to receive an email when new articles are posted on . Sentinel lymph node biopsy was effective as a prognostic and staging tool in stage IIB/C melanoma, according to ...

Skipping sentinel lymph node biopsy (SLNB) in patients with clinically node-negative, hormonal receptor (HR)-positive, HER2-negative early-stage breast cancer did not compromise regional control or ...